Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Stefano Luminari, Maria Goldaniga, Marina Cesaretti, Lorella Orsucci, Alessandra Tucci, Alessandro Pulsoni, Flavia Salvi, Luca Arcaini, Angelo Michele Carella, Alessandra Tedeschi, Antonello Pinto, Caterina Stelitano & Luca Baldini. (2016) A phase II study of bendamustine in combination with rituximab as initial treatment for patients with indolent non-follicular non-Hodgkin lymphoma. Leukemia & Lymphoma 57:4, pages 880-887.
Read now
Read now
Articles from other publishers (11)
. 2018. Diagnostic Pathology: Blood and Bone Marrow. Diagnostic Pathology: Blood and Bone Marrow
774
779
.
L. Aresu, V. Martini, F. Rossi, M. Vignoli, M. Sampaolo, A. Aricò, P. Laganga, A. Pierini, P. Frayssinet, R. Mantovani & L. Marconato. (2015) Canine indolent and aggressive lymphoma: clinical spectrum with histologic correlation. Veterinary and Comparative Oncology 13:4, pages 348-362.
Crossref
Crossref
Heba Degheidy, Siddha Kasar, Chingiz Underbayev, Yao Yuan, Smruti Mehta, Marilyn Lightfoote, Gerald Marti & Elizabeth Raveche. 2014. MicroRNA in Development and in the Progression of Cancer. MicroRNA in Development and in the Progression of Cancer
159
178
.
Andrea L. Russo, Yu-Hui Chen, Neil E. Martin, Anant Vinjamoori, Sarah K. Luthy, Arnold Freedman, Evan M. Michaelson, Barbara Silver, Peter M. Mauch & Andrea K. Ng. (2013) Low-Dose Involved-Field Radiation in the Treatment of Non-Hodgkin Lymphoma: Predictors of Response and Treatment Failure. International Journal of Radiation Oncology*Biology*Physics 86:1, pages 121-127.
Crossref
Crossref
Andrea Ferrario, Alessandro Pulsoni, Barbara Olivero, Giuseppe Rossi, Umberto Vitolo, Alessandra Tedeschi, Francesco Merli, Luigi Rigacci, Caterina Stelitano, Maria Goldaniga, Donato Mannina, Pellegrino Musto, Francesca Rossi, Enrica Gamba & Luca Baldini. (2011) Fludarabine, cyclophosphamide, and rituximab in patients with advanced, untreated, indolent B‐cell nonfollicular lymphomas. Cancer 118:16, pages 3954-3961.
Crossref
Crossref
Basem M. William, Tracey Harbert, Apar K. Ganti & Philip J. Bierman. (2011) Small lymphocytic lymphoma in a patient with CREST syndrome. Hematology/Oncology and Stem Cell Therapy 4:3, pages 132-135.
Crossref
Crossref
Andrea Ferrario, Francesco Merli, Stefano Luminari, Caterina Stelitano, Donato Mannina, Mario Russo, Patrizio Mazza, Luigi Marcheselli, Maria Cecilia Goldaniga, Massimo Federico & Luca Baldini. (2010) Phase II fludarabine and cyclophosphamide for the treatment of indolent B cell non-follicular lymphomas: final results of the LL02 trialof the Gruppo Italiano per lo Studio dei Linfomi (GISL). Annals of Hematology 90:3, pages 323-330.
Crossref
Crossref
Sherrie L. Perkins. 2011. Diagnostic Pediatric Hematopathology. Diagnostic Pediatric Hematopathology
395
428
.
BS Wilkins. 2011. Blood and Bone Marrow Pathology. Blood and Bone Marrow Pathology
419
449
.
Dimitris J. Apostolopoulos, Nikolaos I. Papandrianos, Argiris Symeonidis, Tryfon Spyridonidis, Sotiria Alexiou, Petros Zampakis, Christos Savvopoulos, Pavlos J. Vassilakos & Panagiota Matsouka. (2010) Technetium-99m depreotide imaging by single photon emission tomography/low resolution computed tomography in malignant lymphomas: comparison with gallium-67 citrate. Annals of Nuclear Medicine 24:9, pages 639-647.
Crossref
Crossref
Massimo Federico, Stefano Molica, Monica Bellei & Stefano Luminari. (2009) Prognostic factors in low-grade non-Hodgkin lymphomas. Current Hematologic Malignancy Reports 4:4, pages 202-210.
Crossref
Crossref